APTEVO THERAPEUTICS
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. They leverage the innovative ADAPTIRâ„¢ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients.Based in Seattle, Washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. As a result, Aptevo has been able to attract some of the most innovative minds in the field. Many of our team members have notable experience with other pioneering biotech companies including Trubion, ZymoGenetics, Immunex, Dendreon, and VLST.
APTEVO THERAPEUTICS
Social Links:
Industry:
Biometrics Biopharma Biotechnology Oncology
Founded:
2016-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.aptevotherapeutics.com
Total Employee:
101+
Status:
Active
Contact:
(888)616-0855
Email Addresses:
[email protected]
Total Funding:
56.95 M USD
Technology used in webpage:
Domain Not Resolving Euro U.S. Server Location
Similar Organizations
ArcherDX
ArcherDX is a biotechnology firm specializing in cancer research.
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Integral Molecular
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.aptevotherapeutics.com Semrush global rank: 8.35 M Semrush visits lastest month: 558
- Host name: client-23-254-131-60.hostwindsdns.com
- IP address: 23.254.131.60
- Location: Seattle United States
- Latitude: 47.4902
- Longitude: -122.3004
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98168
More informations about "Aptevo Therapeutics"
About Us - Aptevo Therapeutics
The Platforms ADAPTIRâ„¢ and ADAPTIR-FLEXâ„¢: Science for the Future of Cancer Treatment. The Company’s proprietary platforms and clinical programs provide opportunities for a broad range of potential partnering and licensing …See details»
Management Team - Aptevo Therapeutics
He also previously served as President and Chief Executive Officer of Kitchen Craft Cabinetry, after occupying the position of VP of Finance and Chief Financial Officer with the organization. Mr. Lamothe’s other past experience includes …See details»
Aptevo Therapeutics - Overview, News & Similar companies
Aug 11, 2024 Explore Complete Organization Structure. Is Aptevo Therapeutics your ideal customer? ... 838-0500 Website: aptevotherapeutics.com What does Aptevo Therapeutics do? …See details»
Aptevo Therapeutics Inc - LinkedIn
Aptevotherapeutics.gcs-web.com 113 2 Comments Like Comment Share Aptevo Therapeutics Inc 3,426 followers 2mo Report this post 64 ...See details»
Aptevo Therapeutics - Crunchbase Company Profile
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. They leverage the innovative ADAPTIRâ„¢ platform technology, a unique approach to cancer …See details»
Aptevo Therapeutics Inc. (APVO) - Yahoo Finance
See the company profile for Aptevo Therapeutics Inc. (APVO) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Aptevo Therapeutics Inc. (APVO) Company Profile & Overview
Nov 22, 2024 2401 4th Avenue, Suite 1050 Seattle, Washington 98121 United StatesSee details»
Investors | Aptevo Therapeutics Inc
May 27, 2020 Aptevo Therapeutics and the ADAPTIRâ„¢ (Modular Protein Technology) Platform: The Future of Immuno-oncology. Aptevo Therapeutics Inc. is a clinical-stage biotechnology …See details»
Aptevo Therapeutics Inc, APVO:NAQ profile - FT.com - Financial …
Nov 22, 2024 Aptevo Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing novel immunotherapy candidates for the treatment of different forms of cancer.See details»
Aptevo Therapeutics Inc. (APVO) - Yahoo Finance
Find the latest Aptevo Therapeutics Inc. (APVO) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Board of Directors - Aptevo Therapeutics
Prior to this role, he served as Vice President of Sales for Tissue Tech Limited, an organization who pioneered the innovative application of human placental tissue in wound healing. From …See details»
Aptevo Therapeutics - Craft
Aptevo Therapeutics has 3 employees at their 1 location and $3.11 m in annual revenue in FY 2022. See insights on Aptevo Therapeutics including office locations, competitors, revenue, …See details»
Aptevo Therapeutics Reports First Complete Remission, Providing ...
Nov 23, 2021 SEATTLE, WA / ACCESSWIRE / November 23, 2021 / Aptevo Therapeutics Inc. ("Aptevo" or the "Company") (NASDAQ:APVO), a clinical-stage biotechnology company …See details»
APVO.O - | Stock Price & Latest News | Reuters
Nov 12, 2024 Get Aptevo Therapeutics Inc (APVO.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsSee details»
Aptevo Therapeutics (APVO) Stock Price, News & Analysis
4 days ago www.aptevotherapeutics.com. Phone (206) 838-0500. Fax 206-838-0503. Employees 50. Year Founded 2016. Price Target and Rating. Average Stock Price Target …See details»
Aptevo Therapeutics Inc. (APVO) - Stock Analysis
Nov 22, 2024 Website https://www.aptevotherapeutics.com. Full Company Profile. Financial Performance. Financial Statements. Analyst Forecast. According to one analyst, the rating for …See details»
Technology - Aptevo Therapeutics
ADAPTIR Bispecifics are based on a robust technology platform with potential advantages over other platforms including; Increased stability and half-life, antibody-like manufacturing, ease of …See details»
APVO Stock Price Quote | Morningstar
Nov 22, 2024 See the latest Aptevo Therapeutics Inc stock price (APVO:XNAS), related news, valuation, dividends and more to help you make your investing decisions.See details»
Pipeline - Aptevo Therapeutics
Therapeutic Candidate Portfolio: Proprietary and Powerful Drug Candidates for the Treatment of Blood and Solid Tumor Malignancies. Aptevo Therapeutics is committed to building a robust …See details»